drugset / Trial / NCT01514877

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

NCT01514877

Phase 2 Completed 20 enrolled Zhejiang Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to explore the efficacy and toxicity of icotinib combined with WBRT in treating patients with multiple brain metastases from NSCLC.

Timeline

Start
2012-01
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Icotinib Small molecule 125 mg Oral